DiaCarta files for emergency authorization of SARS-CoV-2 test

By LabPulse.com staff writers

March 24, 2020 -- DiaCarta said it has filed an emergency use authorization (EUA) application for its QuantiVirus SARS-CoV-2 test with the U.S. Food and Drug Administration. The test has also received the CE Mark in Europe.

The company noted that it has validated the novel coronavirus/COVID-19 diagnostic test in its own CLIA-certified lab in Richmond, CA, to provide testing services for healthcare providers and patients. Based on real-time polymerase chain reaction (PCR) technology, the IVD test is designed to specifically detect SARS-CoV-2 viral DNA extracted from nasopharyngeal swabs, oropharyngeal swabs, and sputum from patients suspected of being infected, according to DiaCarta.

The assay targets three genes of SARS-CoV-2: N, Orf1ab, and E. In studies, the test demonstrated 96.7% sensitivity and 100% specificity, with no cross-reaction to different types of non-SARS-CoV-2 species, DiaCarta said.

CTK debuts 2 new coronavirus tests internationally
CTK has developed a polymerase chain reaction-based nucleic acid detection kit and a serological rapid screening test for use in detecting SARS-CoV-2,...
FDA grants EUA to Thermo's coronavirus diagnostic test
The U.S. Food and Drug Administration (FDA) on March 13 granted emergency use authorization (EUA) to Thermo Fisher Scientific for a diagnostic kit to...
Vendors, labs scramble to meet needs of coronavirus outbreak
The outbreak of the novel coronavirus is putting a strain on diagnostics manufacturers and clinical labs as they struggle to meet the need for more testing....
FDA moves to improve coronavirus testing access
The U.S. Food and Drug Administration (FDA) has taken two actions in an effort to improve access to coronavirus testing.
3 ways the U.S. went wrong with COVID-19 testing
Diagnostic testing for any new virus is crucial to its containment, but since the COVID-19 outbreak began, the U.S. has made a number of missteps that...

Copyright © 2020 LabPulse.com

Last Updated np 3/24/2020 11:07:39 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current